复髓化药物的临床试验中的视觉结果措施

Gioia Riboni-Verri1,2, Benson S Chen1,2, Christopher E McMurran1,2,3

  • 1Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.

BMJ neurology open
|February 23, 2024
PubMed
概括

增强复髓化和限制轴突退化是减缓多发性硬化症 (MS) 进展的关键. 本综述审查了在临床试验中评估复髓化疗法的视觉结果措施.